Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 23,499 | 20,123 | 11,147 | 12,853 | 9,040 |
| Gross Profit | 23,499 | 20,123 | 11,147 | 12,853 | 9,040 |
| Operating Expenses | 29,152 | 29,632 | 40,857 | 42,907 | 41,102 |
| Operating Income | -5,653 | -9,509 | -29,710 | -30,054 | -32,062 |
| Other Income | 2,342 | 733 | 646 | 558 | 81 |
| Pre-tax Income | -3,311 | -8,776 | -29,064 | -29,496 | -31,981 |
| Net Income Continuous | -3,311 | -8,776 | -29,064 | -29,496 | -31,981 |
| Net Income | $-3,311 | $-8,776 | $-29,064 | $-29,496 | $-31,981 |
| EPS Basic Total Ops | -0.05 | -0.13 | -0.44 | -0.45 | -0.49 |
| EPS Basic Continuous Ops | -0.05 | -0.13 | -0.44 | -0.45 | -0.49 |
| EPS Diluted Total Ops | -0.05 | -0.13 | -0.44 | -0.45 | -0.49 |
| EPS Diluted Continuous Ops | -0.05 | -0.13 | -0.44 | -0.45 | -0.49 |
| EBITDA(a) | $-6,593 | $-8,906 | $-29,101 | $-29,460 | $-31,477 |